Damora Therapeutics, Inc. (DMRA) vs Harrow Health, Inc. (HROW)
A side-by-side comparison of Damora Therapeutics, Inc. and Harrow Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$20.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
HROW
Harrow Health, Inc.
$30.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — DMRA vs HROW
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)HROW +541.1% (+36.3%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
DMRA HROW
DMRA vs HROW: by the numbers
- •DMRA is the larger company ($1.24B vs $1.14B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -13.51% net margin).
Metrics side by side
Valuation
| Metric | DMRA | HROW |
|---|---|---|
| P/S ratio | N/A | 4.14 |
| P/B ratio | 3.22 | 74.99 |
| FCF yield | N/A | 0.46% |
Profitability
| Metric | DMRA | HROW |
|---|---|---|
| Gross margin | 0.00% | 73.28% |
| Operating margin | 0.00% | 14.18% |
| Net margin | 0.00% | -13.51% |
| ROE | -50.93% | -244.91% |
| ROIC | -52.44% | 1.81% |
Growth (annualized)
| Metric | DMRA | HROW |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 34.52% |
| Total return CAGR (5Y) | -25.05% | 27.66% |
Frequently asked
- How have DMRA and HROW total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and HROW delivered 27.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Damora Therapeutics ROEHarrow Health ROEDamora Therapeutics operating marginHarrow Health operating marginDamora Therapeutics revenue growthHarrow Health revenue growthDamora Therapeutics free cash flowHarrow Health free cash flow
Damora Therapeutics & Harrow Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.